Company to sell some medicines at a discount to US’s Medicaid health plan in exchange for tariff relief
Donald Trump announced a deal with the British-based drugmaker AstraZeneca for a “most-favored-nation” drug-pricing model aimed at making prescription medicines more affordable and avoiding the administration’s tariff threats.
The company will sell some medicines at a discount to the government’s Medicaid health plan in exchange for tariff relief, similar to a drug-pricing pact reached last week with Pfizer.
Continue reading...source https://www.theguardian.com/us-news/2025/oct/10/trump-astrazeneca-drug-prices
No comments:
Post a Comment